RK

Robert Kopple

North America, California, United States, Los Angeles

Description

Robert Kopple

Investor Profile

Robert Kopple has made 3 investments, with 1 in the past 12 months and 33% as lead.

Stage Focus

  • Series Unknown (67%)
  • Convertible Note (33%)

Country Focus

  • United Kingdom (67%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Finance
  • Financial Services
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Robert Kopple frequently co-invest with?

EOS Technology Investment Syndicate
Europe, Fife, United Kingdom, Saint Andrews
Co-Investments: 2
Medical Incubator Japan
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Scottish Enterprise
Europe, Glasgow City, United Kingdom, Glasgow
Co-Investments: 2

What are some of recent deals done by Robert Kopple?

ILC Therapeutics

Newhouse, North Lanarkshire, United Kingdom

ILC Therapeutics is an early-stage biotechnology company focused on modulating the Innate Immune System.

BiotechnologyHealth CareLife Science
Series UnknownSep 11, 2024
Amount Raised: $3,259,537
ILC Therapeutics

Newhouse, North Lanarkshire, United Kingdom

ILC Therapeutics is an early-stage biotechnology company focused on modulating the Innate Immune System.

BiotechnologyHealth CareLife Science
Series UnknownSep 6, 2021
Amount Raised: $4,843,526
Tradier

Charlotte, North Carolina, United States

Tradier offers developers, trading platform providers and investors an innovative trading platform and a rich set of real-time APIs.

FinanceFinancial ServicesFinTech
Convertible NoteOct 15, 2016
Amount Raised: $3,000,000